Related by context. All words. (Click for frequent words.) 72 hypertensives 71 antihypertensive therapy 68 antihypertensive medications 67 antihypertensive drugs 66 hypertension 66 candesartan 65 HbA1c levels 65 HbA 1c 64 serum uric acid 64 antihypertensive agents 64 statin therapy 64 allopurinol 64 resistant hypertension 64 antihypertensive medication 63 systolic hypertension 63 lipid levels 63 Lp PLA2 63 hemoglobin A1c HbA1c 63 lipid lowering therapy 63 serum phosphorus 63 glycated hemoglobin levels 63 fluvastatin 63 beta blocker therapy 63 macrovascular disease 63 stable angina 63 ATACAND 63 LDL C 63 hemoglobin A1c levels 63 benazepril 63 glycemia 62 angiotensin receptor blockers ARBs 62 serum potassium 62 cardiovascular mortality 62 #/#mmHg 62 telmisartan 62 cirrhotic patients 62 A1C levels 62 hemodialysis patients 62 NATRECOR R 62 elevated triglyceride levels 62 elevated LDL cholesterol 62 BENICAR 62 HbA1C 62 angiotensin II receptor blockers 62 mm Hg systolic 62 rFVIIa 62 HbA1c 62 T2DM 62 Atacand 62 microvascular complications 61 antihypertensive 61 hypercholesterolemia 61 lipid parameters 61 hs CRP 61 baseline HbA1c 61 microalbuminuria 61 intensive statin therapy 61 #mmHg [001] 61 platelet reactivity 61 cardiovascular morbidity 61 trials RCTs 61 platelet inhibition 61 pioglitazone 61 A1c levels 61 dosage regimens 61 cinacalcet 61 dyslipidaemia 61 antihypertensives 61 LV dysfunction 60 nicardipine 60 mmHg diastolic 60 tirofiban 60 mmHg 60 hypercholesterolaemia 60 nondiabetic patients 60 thiazide diuretics 60 severe exacerbations 60 olmesartan 60 diabetics 60 β blockers 60 mm Hg diastolic 60 ischemic stroke 60 randomized trials 60 orthostatic hypotension 60 left ventricular dysfunction 60 serum creatinine levels 60 irbesartan 60 angiotensin receptor blockers 60 glucose lowering 60 nondiabetics 60 atherogenic dyslipidemia 60 ruboxistaurin 60 albuminuria 60 eptifibatide 60 insulin detemir 60 AZOR 60 rosuvastatin 60 kidney transplant recipients 60 liver transplant recipients 60 sulphonylureas 60 ACCORD Lipid 60 NSTE ACS 60 proteinuria 60 angiotensin converting enzyme inhibitors 60 hyperkalemia 60 lowering LDL cholesterol 60 serum calcium 60 ximelagatran 60 elevated uric acid 60 thrombotic events 60 serum cholesterol 59 systolic BP 59 renal dysfunction 59 Rasilez Tekturna 59 asymptomatic carotid stenosis 59 aliskiren 59 BENICAR HCT 59 aldosterone antagonists 59 sUA 59 acute coronary syndrome 59 hsCRP 59 valsartan 59 prescribed statins 59 Telmisartan 59 paricalcitol 59 #mmHg [002] 59 renal artery stenosis 59 subclinical hypothyroidism 59 candesartan cilexetil 59 dose atorvastatin 59 glomerular filtration 59 statins 59 HbA 1c levels 59 clopidogrel 59 eplerenone 59 Hypotension 59 bezafibrate 59 ALLHAT 59 periprocedural 59 hypoglycemic events 59 mm Hg 59 Ramipril 59 hyperphosphatemia 59 carotid stenosis 59 serum urate levels 59 oral antidiabetic medication 59 isolated systolic hypertension 59 ACE inhibitors 59 arterial thromboembolic events 58 serum phosphate levels 58 thromboembolic events 58 STEMI patients 58 anticoagulation 58 systolic 58 recurrent VTE 58 anti hypertensive 58 HIV HCV coinfected 58 ABPM 58 macrovascular events 58 elevated CRP 58 ramipril 58 diastolic BP 58 systolic dysfunction 58 A1c 58 lumiracoxib 58 teriflunomide 58 inflammatory biomarkers 58 anticholinergics 58 UA NSTEMI 58 fasting glucose levels 58 revascularization procedures 58 hyperphenylalaninemia HPA due 58 normotensive 58 angiotensin receptor blocker ARB 58 severe renal impairment 58 poor metabolizers 58 glitazones 58 Hb A1C 58 ejection fractions 58 #mg dose [001] 58 randomized clinical trials 58 EDARBI 58 severe hypoglycemia 58 dose clopidogrel 58 uncontrolled hypertension 58 angiotensin converting enzyme inhibitor 58 coronary blockages 58 Combination therapy 58 hypoglycemic episodes 58 ARIXTRA 58 verapamil 58 hyperglycaemia 58 ACEIs 58 NovoLog ® Mix 58 renal impairment 58 fasting glucose 58 antiplatelet therapy 58 fasting plasma glucose 58 NYHA class 58 patients undergoing CABG 58 serum glucose 58 losartan 58 improves glycemic 58 acarbose 58 macrovascular 58 MICARDIS ® 58 LDL Cholesterol 58 uric acid levels 58 ischemic cardiomyopathy 58 Stop Hypertension diet 58 salmeterol fluticasone 58 mmHg systolic 58 calcium supplementation 58 blood lipids 57 NPH insulin 57 proliferative diabetic retinopathy 57 SHPT 57 antidiabetic drugs 57 serum urate 57 Diovan HCT 57 glycosylated hemoglobin HbA1c 57 thromboembolic 57 elevated fasting glucose 57 lipid abnormalities 57 triglyceride levels 57 serum phosphorous 57 SCIg 57 plasma renin activity 57 mixed hyperlipidemia 57 hemoglobin A1c 57 K DOQI 57 prospective randomized placebo 57 lipid lowering medications 57 atorvastatin #mg 57 thiazide diuretic 57 MULTAQ 57 coadministration 57 primary aldosteronism 57 cystatin C 57 perindopril 57 insulin glargine 57 Trandolapril 57 CrCl 57 cholesterol LDL C 57 valsartan amlodipine 57 CK MB 57 Hypertension 57 metformin sulphonylurea 57 DU #b 57 lipid lowering drugs 57 pulmonary capillary wedge 57 prehypertension 57 prehypertensive 57 hyperlipidaemia 57 rizatriptan 57 fosamprenavir 57 C reactive protein 57 aldosterone 57 alpha blocker 57 diabetes mellitus 57 vertebral fracture 57 alpha blockers 57 lipid lowering agents 57 chlorthalidone 57 dyslipidemia 57 LDL cholesterol levels 57 serum phosphate 57 rosuvastatin #mg 57 abdominal adiposity 57 COPD exacerbations 57 oral antidiabetic drugs 57 glycosylated hemoglobin 57 CRESTOR #mg 57 amlodipine 57 LDL lowering 57 aripiprazole 57 COREG 57 elevated triglycerides 57 acute coronary syndromes 57 pyridostigmine 57 multivessel disease 57 QVAR R 57 tenecteplase 57 cilostazol 57 contrast induced nephropathy 57 lowering systolic blood 57 DAPT 57 clinically meaningful reductions 57 Stop Hypertension DASH diet 57 antiplatelet drugs 57 impaired fasting glucose 57 carvedilol 57 active comparator 57 #mg/dL [001] 57 RE LY ® 57 angiotensin II receptor blocker 57 UKPDS 57 T1DM 57 intracerebral haemorrhage 57 oral antidiabetic medications 57 BARI 2D 57 aldosterone antagonist 57 cerebrovascular events 57 glulisine 57 symptomatic hypotension 57 CYP#C# [001] 57 fasting triglyceride levels 57 dalteparin 57 systolic blood pressure 57 NATRECOR ® 57 A1C 57 virologic failure 57 abnormal glucose tolerance 57 azacitidine 57 COPAXONE R 57 transferrin saturation 57 mycophenolate mofetil 57 dose statin therapy 57 LDL cholesterol concentrations 57 postoperative AF 57 migraine sufferers 56 tranylcypromine 56 hepatotoxicity 56 recurrent stroke 56 reflux symptoms 56 left ventricular hypertrophy 56 renal tumors 56 cerebral infarction 56 glargine 56 colorectal adenoma 56 impaired glucose tolerance 56 subclinical atherosclerosis 56 LEXIVA 56 anticlotting drugs 56 titrated glipizide 56 PRADAXA #mg 56 LDL cholesterol lowering 56 ezetimibe simvastatin 56 uncontrolled asthma 56 pre menopausal 56 patients 56 haemorrhagic stroke 56 hyperglycemia 56 chronic thromboembolic pulmonary 56 asthma exacerbation 56 plasma triglycerides 56 Lipid Lowering Treatment 56 certolizumab 56 statin 56 rosuvastatin Crestor 56 pioglitazone Actos 56 biphasic insulin aspart 56 prednisone prednisolone 56 endarterectomy 56 placebo controlled studies 56 thyroxine 56 phosphate binders 56 artery stenosis 56 plasma glucose levels 56 virological failure 56 ritonavir boosted 56 ischemic strokes 56 AEGR 56 Rheumatologists 56 dysglycemia 56 creatinine clearance 56 myopathy rhabdomyolysis 56 venlafaxine Effexor 56 fructose diet 56 diabetes mellitus DM 56 esomeprazole 56 antithrombotic 56 Tiotropium 56 cardioprotective effects 56 randomized clinical 56 fondaparinux 56 ADHF 56 lamotrigine 56 lacosamide 56 blood Phe levels 56 alanine aminotransferase ALT 56 warfarin therapy 56 diuretic chlorthalidone 56 abacavir lamivudine 56 polyp recurrence 56 placebo controlled trials 56 eprotirome 56 triacylglycerol concentrations 56 HCTZ 56 HbA1C levels 56 clozapine 56 hemorrhagic complications 56 solifenacin 56 thrombolytic therapy 56 serum concentrations 56 prostate cancer CaP 56 A1Cs 56 intravesical therapy 56 paclitaxel eluting stents 56 sirolimus 56 preserved ejection fraction 56 ACTOS 56 OAB symptoms 56 edoxaban 56 glycated hemoglobin 56 lupus nephritis 56 ARCOXIA 56 ACE inhibitor 56 tocilizumab 56 atorvastatin Lipitor 56 postoperative atrial fibrillation 56 coronary revascularization 56 upper gastrointestinal bleeding 56 coronary disease 56 reinfarction 56 anticoagulation therapy 56 serum lipid levels 56 Valsartan 56 leukotriene receptor antagonists 56 hypertensive 56 beta blocker 56 serum calcium levels 56 urinary albumin excretion 56 antiplatelet agents 56 lymphocyte counts 56 glycemic control 56 lipid lowering therapies 56 SORT OUT III 56 Anticoagulants 56 insulin sensitizing 56 typical antipsychotics 56 tolvaptan 56 ezetimibe Zetia 56 blood Phe 56 nondiabetic 56 nonadherence 56 Pioglitazone 56 Procoralan 56 visilizumab 56 plasma folate 56 dose regimens 56 mmol l 56 rt PA 56 TZDs 56 Protelos 56 perioperatively 56 xanthine oxidase inhibitor 56 noncardiac surgery 56 ACE Inhibitor 56 Cardiovascular Risk 56 PRADAXA 56 RCTs 56 leukocyte count 56 pharmacokinetic PK profile 56 subgroup analyzes 56 ULORIC 56 BARACLUDE ® 56 nonrandomized 56 subanalysis 56 iPTH 56 fluticasone salmeterol 56 VADT 56 nonfasting triglyceride levels 56 postprandial glucose 56 ivabradine 56 APTIVUS r 56 paroxysmal AF 56 coronary interventions 56 canakinumab 56 thiazide 56 XIENCE V PROMUS Stent 56 anticholinergic medications 56 Lp PLA 2 56 randomized controlled trials 56 OADs 56 coinfected patients 56 atherothrombosis 56 HYVET 56 thrombocytopenic 56 hsCRP levels 56 maximally tolerated doses 56 CMV infection 55 urinary tract symptoms LUTS 55 sunitinib 55 antithrombotic therapy 55 perimenopausal women 55 beclomethasone dipropionate 55 peginterferon alfa 2a 55 nonfasting 55 clevidipine 55 incontinence episodes 55 nephrotoxicity 55 chlorambucil 55 stenoses 55 antiplatelet 55 GnRH agonists 55 microvascular disease 55 diastolic heart 55 heavily pretreated 55 losartan Cozaar 55 decompensated heart failure 55 urate levels 55 warfarin 55 TEAEs 55 atherothrombotic events 55 atherosclerotic disease 55 Prehypertension 55 prescribing statins 55 eGFR 55 CYPHER Stent 55 thrombocytopenic patients 55 comorbid conditions 55 riociguat 55 glycemic variability 55 systemic corticosteroids 55 Fibrates 55 serum triglycerides 55 abacavir Ziagen 55 metformin Glucophage 55 hypogonadal men 55 abciximab 55 plasma glucose 55 antidiabetic drug 55 metformin sulfonylurea 55 vildagliptin 55 INVEGA R 55 Candesartan 55 octreotide LAR 55 NAFLD 55 severe hypoglycaemia 55 angina 55 carotid plaque 55 elevated serum creatinine 55 PREZISTA r 55 Acute Coronary Syndrome 55 hemorrhagic strokes 55 NYHA Class II 55 HoFH 55 antiplatelet agent 55 platelet function 55 LEXIVA r 55 diabetic nephropathy 55 cholesterol lowering medication 55 bronchial thermoplasty 55 HBeAg seroconversion 55 tacrolimus 55 aminotransferases 55 clomipramine 55 subclinical hyperthyroidism 55 dabigatran etexilate 55 statin monotherapy 55 cardiovascular disease 55 lipid lowering 55 DASH diet 55 ACE Inhibitors 55 exacerbations 55 prescribe statins 55 mL/min/#.# m 2 55 Nesiritide 55 stone formers 55 Antihypertensive 55 LVEF 55 serum phosphorus levels 55 VAPRISOL 55 ACE inhibitor ramipril 55 type2 diabetes 55 NYHA functional class 55 myocardial infarction MI 55 MELD scores 55 myocardial infarction 55 6R BH4 55 diastolic blood pressures 55 hydroxyvitamin D levels 55 macroalbuminuria 55 vasomotor symptoms 55 primary hypercholesterolemia 55 REMICADE ® 55 OPCAB 55 albumin excretion rate 55 fibrates 55 montelukast 55 dronedarone 55 #.#mmol L [002] 55 #mm Hg 55 non valvular atrial 55 CVD mortality 55 postprandial glycemia 55 HBeAg positive 55 coronary heart 55 platelet aggregation 55 acute ischemic stroke 55 neutrophil counts 55 triglyceride concentrations 55 inadequate glycemic 55 renal insufficiency 55 serum triglyceride levels 55 ACTEMRA TM 55 angiotensin receptor blocker 55 total cholesterol triglycerides 55 Events MACE 55 evaluable subjects 55 ticlopidine 55 bosentan 55 eosinophil count 55 lomitapide 55 T2D 55 lispro 55 advanced adenomas 55 aspirin clopidogrel 55 enalapril 55 pioglitazone HCl 55 statin medications 55 WelChol 55 eosinophilic asthma 55 calcium antagonists 55 detemir 55 prospective randomized 55 hemoglobin A1C 55 aspirin regimen 55 bypass graft CABG surgery 55 colorectal liver metastases 55 serum sodium 55 beta blocker atenolol 55 vasodilators 55 antiepileptic drugs AEDs 55 postprandial hyperglycemia 55 hyperuricemia 55 POAG 55 ESRD patients 55 carotid atherosclerosis 55 recurrent venous thromboembolism 55 mg/m2 dose 55 adalimumab 55 intima media thickness 55 anticoagulant warfarin 55 Aliskiren 55 CIMZIA ™ 55 conventional antipsychotics 55 placebo controlled clinical 55 tricyclic antidepressants 55 tiotropium 55 thiazolidinedione TZD 55 clopidogrel Plavix 55 testosterone supplementation 55 white matter hyperintensities 55 PICSO ® 55 preoperative chemotherapy 55 NT proBNP 55 nocturnal hypoglycaemia 55 overt nephropathy 55 severe hypoglycemic 55 protease inhibitor PI 55 idraparinux 55 Avandia Actos 55 acute coronary 55 TNF antagonist 55 ejection fraction 55 VTE prophylaxis 55 coronary stenosis 55 coronary artery disease 55 PSADT 55 aspartate aminotransferase AST 55 gout flares 55 nonvertebral fractures 55 arterial stiffness 55 intracerebral hemorrhage 55 spironolactone 55 elevated creatinine 55 metastatic renal cell carcinoma 55 Instanyl 54 myocardial infarctions 54 plasma concentrations 54 CTAP# Capsules 54 Critical Limb Ischemia CLI 54 serum cortisol 54 atherothrombotic disease 54 IFN beta 54 blood glucose levels 54 pentoxifylline 54 Ranolazine 54 glycosylated hemoglobin levels 54 troponin T 54 peginterferon 54 diastolic hypertension 54 umol L 54 ACCOMPLISH 54 blood phenylalanine Phe 54 INCB# [003] 54 severe neutropenia 54 cardiac troponin T 54 beta2 agonist 54 migraineurs 54 dose cytarabine 54 atherosclerotic renal artery stenosis 54 antiarrhythmic drug 54 severe aortic stenosis 54 co morbidities 54 ARB telmisartan 54 gliclazide 54 baseline LDH 54 Cardiovascular Outcomes 54 ß blockers 54 D dimer 54 venous thrombosis 54 Dabigatran 54 myocardial uptake 54 abnormal lipids 54 febuxostat 54 colesevelam HCl 54 alteplase 54 Sitagliptin 54 HDL C 54 AVANDIA 54 rosiglitazone 54 glitazone 54 patients undergoing percutaneous 54 thromboembolism 54 timepoints 54 antiplatelet medications 54 hypoglycemia 54 homocysteine concentrations 54 Thrombolysis 54 EURIDIS 54 clazosentan 54 venous thromboembolism 54 inhaled steroids 54 systolic blood pressures 54 lowering blood glucose 54 TMC# r 54 acute coronary syndromes ACS 54 interferon therapy 54 MADIT II 54 undergoing coronary artery 54 ACE inhibitor perindopril 54 amiodarone 54 glipizide 54 Fonarow 54 #mg/dl 54 #mg dose [003] 54 overactive bladder symptoms 54 HOMA IR 54 Durezol 54 inflammatory markers 54 glycated hemoglobin HbA1c 54 myelosuppression 54 nonischemic 54 cardiac toxicity 54 diabetic neuropathic pain 54 postoperative mortality 54 #mg doses [002] 54 antiangiogenic therapy 54 inflammatory acne 54 acute myocardial infarction AMI 54 thromboprophylaxis 54 symptomatic BPH 54 adiponectin concentrations 54 nonvertebral fracture 54 antihypertensive regimen 54 TAXUS Stent 54 thiazides 54 VTE 54 creatinine levels 54 double blinded placebo 54 beta blockers 54 alcoholic fatty liver 54 glycoprotein IIb IIIa inhibitors 54 posaconazole 54 undergone radical prostatectomy 54 inotropic 54 Tolvaptan 54 somatostatin analogs 54 Lipitor #mg 54 intracranial hemorrhage ICH 54 RESIST studies 54 milrinone 54 primidone 54 Thiazolidinediones 54 pitavastatin 54 Apidra ® 54 antiarrhythmic drugs 54 Chronic Heart Failure 54 neuropsychiatric symptoms 54 loop diuretics 54 tHcy 54 LDL 54 infarction STEMI 54 noninferiority 54 cardiovascular 54 LDL cholesterol 54 Subgroup analyzes 54 Fasting glucose 54 multicenter randomized 54 sulphonylurea 54 enoxaparin 54 plasma lipid 54 OGTT 54 renal toxicity 54 sodium glucose cotransporter 54 pg mL 54 insulin sensitizers 54 reblockage 54 symptomatic fibroids 54 nesiritide 54 vitamin D supplementation 54 lactic acidosis 54 PROactive study 54 CIPN 54 Bivalirudin 54 tamsulosin 54 QTc prolongation 54 microbleeds 54 virological response 54 bolus dose 54 hypertonic saline 54 simvastatin ezetimibe 54 Losartan 54 bioavailable testosterone 54 apoB 54 bisphosphonate therapy 54 HDL cholesterol triglycerides 54 hyperphosphataemia 54 hypoglycaemia 54 pressor response 54 lipid lowering medication 54 intact parathyroid hormone 54 rehospitalization 54 systemic embolism 54 ginkgo biloba extract 54 CK # plasma concentrations 54 symptomatic intracranial hemorrhage 54 stratifying patients 54 cirrhotic 54 hypotension 54 #.#mmol l [002] 54 hypotensive 54 Zileuton 54 relapsed SCLC 54 HGPIN 54 homocysteine levels 54 resynchronization therapy 54 adjunctive placebo 54 BYSTOLIC 54 sweat chloride 54 glomerular filtration rate 54 aminotransferase ALT 54 relapsing MS 54 unfractionated heparin 54 alemtuzumab treated 54 ischemic 54 homozygous familial hypercholesterolemia 54 lipid profiles 54 carotid IMT 54 mmol L 54 LMWH 54 fenretinide 54 LVSD 54 cranial irradiation 54 fasting plasma glucose FPG 54 acute PAO 54 labetalol 54 asthma exacerbations 54 bronchial hyperresponsiveness 54 infarct size 54 CC genotype 54 hepatitis C genotype 54 Hb levels 54 carotid plaques 54 risperidone Risperdal 54 HNSCC 54 trandolapril 54 ICD implantation 54 KIF6 carriers 54 ischemic cardiovascular 54 diabetic kidney 54 chromium picolinate supplementation 54 elevated ALT 54 severe psoriasis 54 anti arrhythmic drug 54 dietary intakes 54 familial hypercholesterolemia 54 gefitinib Iressa 54 IBS symptoms 54 blood glucose concentrations 54 nonresponders 54 virologic response 53 HSCT 53 darapladib 53 drugs hydralazine 53 HPA axis suppression 53 Lantus ® 53 thrombotic complications 53 GERD symptoms 53 ® pioglitazone HCl 53 lanthanum carbonate 53 NSAID therapy 53 newer antipsychotics 53 silent ischemia 53 acute STEMI 53 factor Xa inhibitor 53 corticosteroid therapy 53 recurrent atrial fibrillation 53 Victoza R 53 lipoprotein levels 53 pramlintide 53 Elitek 53 intravenous bisphosphonates 53 relapsed MM 53 odanacatib 53 Celebrex celecoxib 53 dose aspirin 53 thiazolidinediones 53 undergoing coronary angiography 53 ticagrelor 53 valvulopathy 53 oxycodone CR 53 methimazole 53 Epidemiologic studies 53 Adalimumab 53 TMP SMX 53 cardiogenic shock 53 ertapenem 53 randomized multicenter 53 paroxetine Paxil 53 antimicrobial prophylaxis 53 Celecoxib APC trial 53 metformin monotherapy 53 coronary artery bypass grafts 53 symptomatic VTE 53 QTc interval 53 Overactive Bladder 53 postmenopausal women 53 serum testosterone 53 chromium supplementation 53 REYATAZ r arm 53 biologic therapy 53 pharmacologic therapy 53 extrapyramidal symptoms 53 liver histology 53 leukopenia 53 bisoprolol 53 non squamous NSCLC 53 Carvedilol 53 FASLODEX 53 Cardiovascular Events 53 induce orthostatic hypotension 53 clinically meaningful improvements 53 μg dose 53 prescribed statin 53 carotid endarterectomy CEA 53 rimonabant #mg 53 symptomatic carotid stenosis 53 dutasteride 53 HCV SPRINT 53 pCR 53 CLA supplementation 53 randomized multicenter trial 53 salmeterol HFA MDI 53 dapagliflozin plus 53 latanoprost 53 serum ALT 53 oral antidiabetes drugs 53 milliliters mL 53 streptokinase 53 Tekamlo 53 post thrombotic syndrome 53 antithrombotics 53 elevated IOP 53 oral FTY# 53 Doxil ® 53 Beta blockers 53 Ischemic 53 Patients Treated 53 aspirin therapy 53 obese adolescents 53 Acute Coronary Syndromes 53 PRISTIQ 53 fasting blood glucose 53 sitagliptin 53 #ng/ml 53 MMSE scores 53 dobutamine 53 APTIVUS 53 dosing frequency 53 angina chest 53 KRAS mutations occur 53 acute myocardial infarction MI 53 XZK 53 Monopril 53 interferon beta therapy 53 comorbidities 53 teriparatide 53 metoprolol tartrate 53 psoriatic arthritis PsA 53 postprandial blood glucose 53 valproate 53 PNH patients 53 channel blockers 53 observational studies 53 inhaled steroid